Literature DB >> 1911113

Pathogenesis of the essential hypertensions.

J G Mongeau1.   

Abstract

The pathogenesis of essential hypertension (EH) is reviewed with a special focus on the development phase or the pre-hypertensive period. Three animal models are presented: the spontaneously hypertensive rat, the Dahl's salt-sensitive rat, and the Milan hypertensive rat. Some of the findings in animal models have inspired new fields and technical approaches for studying EH in man. From the original idea of Page, a new mosaic of various etiological parameters serves as a basis for reviewing the multiple facets of EH in man. One must conclude that EH is heterogeneous disease and most likely every single hypertensive patient belongs to a subgroup of the whole population of hypertensives.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911113     DOI: 10.1007/bf01453667

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  88 in total

1.  Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension.

Authors:  E Laufer; G L Jennings; P I Korner; E Dewar
Journal:  Hypertension       Date:  1989-02       Impact factor: 10.190

2.  Platelet phospholipase C activity in salt-dependent hypertension.

Authors:  I Limon; J Blanc; S Koutouzov; A Knorr; P Meyer; P Marche
Journal:  Hypertension       Date:  1990-04       Impact factor: 10.190

3.  Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat.

Authors:  W V Judy; A M Watanabe; D P Henry; H R Besch; W R Murphy; G M Hockel
Journal:  Circ Res       Date:  1976-06       Impact factor: 17.367

4.  Pre- and neonatal exposure of the Dahl rat to NaCl: development and regional distribution of myocardial alpha 1-adrenergic and cholinergic receptor sites.

Authors:  J A McCaughran; C J Juno; R Friedman
Journal:  J Auton Nerv Syst       Date:  1986-06

5.  1,2-diacylglycerol content in thoracic aorta of spontaneously hypertensive rats.

Authors:  K Okumura; J Kondo; Y Shirai; M Muramatsu; Y Yamada; H Hashimoto; T Ito
Journal:  Hypertension       Date:  1990-07       Impact factor: 10.190

Review 6.  Insulin, insulin sensitivity and hypertension.

Authors:  P Ferrari; P Weidmann
Journal:  J Hypertens       Date:  1990-06       Impact factor: 4.844

7.  Plasma atrial natriuretic peptide in young normotensive subjects with a family history of hypertension and in young hypertensive patients.

Authors:  A Santucci; C Ferri; I Cammarella; S Valentino; C Bellini; S Tani; A Musca; F Balsano
Journal:  Am J Hypertens       Date:  1990-10       Impact factor: 2.689

8.  Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for major-locus inheritance.

Authors:  S J Hasstedt; L L Wu; K O Ash; H Kuida; R R Williams
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

9.  Reduced urinary excretion of prostaglandin E in essential hypertension.

Authors:  K Sato; K Abe; M Seino; M Yasujima; S Chiba; M Sato; T Haruyama; M Hiwatari; T Goto; J Tajima; M Tanno; K Yoshinaga
Journal:  Prostaglandins Leukot Med       Date:  1983-06

10.  Racial differences of parameters associated with blood pressure levels in children--the Bogalusa heart study.

Authors:  G S Berenson; A W Voors; L S Webber; E R Dalferes; D W Harsha
Journal:  Metabolism       Date:  1979-12       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.